About the Team
The BRCA-DIRECT Team is based from the Institute of Cancer Research in Sutton, forming part of the Translational Genetics Team. We are a group funded by Cancer Research UK, and are working in collaboration with SHORE-C in Sussex, The Royal Marsden Hospital in London, Manchester University NHS Foundation Trust and Manchester University to deliver this innovative new study.
Our lab, the NHS North Thames Genomic Laboratory Hub NIHR Biomedical Research Centre for Molecular Pathology, is based at The Royal Marsden Hospital in Sutton. The lab is an NeQAS-approved, ISO 15189 accredited medical diagnostic molecular genetics laboratory. Sample handling, sequencing, and reporting is performed to NHS diagnostic standard.
Below is a list of our key study investigators - if you would like to contact us about the study, please visit our Contact page for details.
Study Co-Investigators
Prof Clare Turnbull
Chief Investigator
The Institute of Cancer research
Dr Angela George
Co-Investigator
The Royal Marsden Hospital
Mr Ashu Gandhi
Co-Investigator
Manchester University NHS Foundation Trust
Prof Dame Lesley Fallowfield
Co-Investigator
SHORE-C
Prof Valerie Jenkins
Co-Investigator
SHORE-C
Ms Rochelle Gold
Patient Representative
BRCA Journey
Prof Gareth Evans
Co-Investigator
Manchester University NHS Foundation Trust
Prof Mike Hubank
Co-Investigator
The Royal Marsden Hospital
Prof Stephen Bremner
Co-Investigator
Brighton & Sussex Clinical Trials Unit (CTU)
Dr Zoe Kemp
Co-Investigator
The Royal Marsden Hospital
Additional Study Collaborators
Grace Kavanaugh
Genetic Counsellor
The Institute of Cancer Research
Ms Nicola Perry
Clinical Trials Manager
Brighton & Sussex Clinical Trials Unit (CTU)
Monica Hamill
Genetic Counsellor
The Institute of Cancer Research
Sophie Allen
Study Coordinator
The Institute of Cancer Research
Dr Christopher Jones
Statistician
Brighton & Sussex Clinical Trials Unit (CTU)